View in EDS PDF Full Text

Safety of third dose of COVID-19 vaccination in frail patients: Results from the prospective Italian VAX4FRAIL study.

Saved in:
Bibliographic Details
Title: Safety of third dose of COVID-19 vaccination in frail patients: Results from the prospective Italian VAX4FRAIL study.
Authors: Di Cosimo S; Department of Applied Research and Technological Development, Fondazione Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milano, Italy., Lupo-Stanghellini MT; Hematology and Bone Marrow Transplantation Unit, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milano, Italy., Costantini M; Scientific Directorate, Fondazione Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milano, Italy., Mantegazza R; Neuromuscular Diseases and Neuroimmunology Unit, Fondazione Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Neurologico Carlo Besta, Milano, Italy., Ciceri F; Hematology and Bone Marrow Transplantation Unit, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milano, Italy.; University Vita-Salute San Raffaele, Milano, Italy., Salvarani C; Unità di Reumatologia, Azienda Unità Sanitaria Locale (USL)-Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Reggio Emilia, Italy.; Unità di Reumatologia, Università degli Studi di Modena e Reggio Emilia, Modena, Italy., Zinzani PL; Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy., Mantovani A; Humanitas Scientific Directorate, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; William Harvey Research Institute, Queen Mary University, London, United Kingdom., Ciliberto G; Scientific Directorate Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Regina Elena, National Cancer Institute, Istituti Fisioterapici Ospitalieri (IFO), Rome, Italy., Uccelli A; Biotherapy Unit, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Policlinico San Martino, Genoa, Italy.; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy., Baldanti F; Molecular Virology Unit, Fondazione Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia, Italy.; Department of Clinical, Surgical, Diagnostics and Pediatric Sciences, University of Pavia, Pavia, Italy., Apolone G; Scientific Directorate, Fondazione Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milano, Italy., Delcuratolo S; Scientific Directorate, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Morrone A; Scientific Directorate, San Gallicano Dermatological Institute Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy., Locatelli F; Department of Pediatric Hematology and Oncology and Cell and Gene Therapy, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Pediatrico Bambino Gesù, Roma, Italy.; Department of Gynecology-Obstetrics and Pediatrics, University 'La Sapienza', Roma, Italy., Agrati C; Cellular Immunology Laboratory, National Institute for Infectious Diseases L Spallanzani - Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy., Silvestris N; Medical Oncology Unit, Department of Human Pathology 'G. Barresi', University of Messina, Messina, Italy.
Source: Frontiers in oncology [Front Oncol] 2022 Oct 20; Vol. 12, pp. 1002168. Date of Electronic Publication: 2022 Oct 20 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36338743
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety of third dose of COVID-19 vaccination in frail patients: Results from the prospective Italian VAX4FRAIL study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Di+Cosimo+S%22">Di Cosimo S</searchLink>; Department of Applied Research and Technological Development, Fondazione Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Lupo-Stanghellini+MT%22">Lupo-Stanghellini MT</searchLink>; Hematology and Bone Marrow Transplantation Unit, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Costantini+M%22">Costantini M</searchLink>; Scientific Directorate, Fondazione Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Mantegazza+R%22">Mantegazza R</searchLink>; Neuromuscular Diseases and Neuroimmunology Unit, Fondazione Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Neurologico Carlo Besta, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Ciceri+F%22">Ciceri F</searchLink>; Hematology and Bone Marrow Transplantation Unit, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milano, Italy.; University Vita-Salute San Raffaele, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Salvarani+C%22">Salvarani C</searchLink>; Unità di Reumatologia, Azienda Unità Sanitaria Locale (USL)-Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Reggio Emilia, Italy.; Unità di Reumatologia, Università degli Studi di Modena e Reggio Emilia, Modena, Italy.<br /><searchLink fieldCode="AU" term="%22Zinzani+PL%22">Zinzani PL</searchLink>; Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Mantovani+A%22">Mantovani A</searchLink>; Humanitas Scientific Directorate, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; William Harvey Research Institute, Queen Mary University, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ciliberto+G%22">Ciliberto G</searchLink>; Scientific Directorate Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Regina Elena, National Cancer Institute, Istituti Fisioterapici Ospitalieri (IFO), Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Uccelli+A%22">Uccelli A</searchLink>; Biotherapy Unit, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Policlinico San Martino, Genoa, Italy.; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.<br /><searchLink fieldCode="AU" term="%22Baldanti+F%22">Baldanti F</searchLink>; Molecular Virology Unit, Fondazione Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia, Italy.; Department of Clinical, Surgical, Diagnostics and Pediatric Sciences, University of Pavia, Pavia, Italy.<br /><searchLink fieldCode="AU" term="%22Apolone+G%22">Apolone G</searchLink>; Scientific Directorate, Fondazione Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori di Milano, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Delcuratolo+S%22">Delcuratolo S</searchLink>; Scientific Directorate, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Tumori 'Giovanni Paolo II', Bari, Italy.<br /><searchLink fieldCode="AU" term="%22Morrone+A%22">Morrone A</searchLink>; Scientific Directorate, San Gallicano Dermatological Institute Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Locatelli+F%22">Locatelli F</searchLink>; Department of Pediatric Hematology and Oncology and Cell and Gene Therapy, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Pediatrico Bambino Gesù, Roma, Italy.; Department of Gynecology-Obstetrics and Pediatrics, University 'La Sapienza', Roma, Italy.<br /><searchLink fieldCode="AU" term="%22Agrati+C%22">Agrati C</searchLink>; Cellular Immunology Laboratory, National Institute for Infectious Diseases L Spallanzani - Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Silvestris+N%22">Silvestris N</searchLink>; Medical Oncology Unit, Department of Human Pathology 'G. Barresi', University of Messina, Messina, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2022 Oct 20; Vol. 12, pp. 1002168. <i>Date of Electronic Publication: </i>2022 Oct 20 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36338743
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2022.1002168
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1002168
    Titles:
      – TitleFull: Safety of third dose of COVID-19 vaccination in frail patients: Results from the prospective Italian VAX4FRAIL study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Di Cosimo S
      – PersonEntity:
          Name:
            NameFull: Lupo-Stanghellini MT
      – PersonEntity:
          Name:
            NameFull: Costantini M
      – PersonEntity:
          Name:
            NameFull: Mantegazza R
      – PersonEntity:
          Name:
            NameFull: Ciceri F
      – PersonEntity:
          Name:
            NameFull: Salvarani C
      – PersonEntity:
          Name:
            NameFull: Zinzani PL
      – PersonEntity:
          Name:
            NameFull: Mantovani A
      – PersonEntity:
          Name:
            NameFull: Ciliberto G
      – PersonEntity:
          Name:
            NameFull: Uccelli A
      – PersonEntity:
          Name:
            NameFull: Baldanti F
      – PersonEntity:
          Name:
            NameFull: Apolone G
      – PersonEntity:
          Name:
            NameFull: Delcuratolo S
      – PersonEntity:
          Name:
            NameFull: Morrone A
      – PersonEntity:
          Name:
            NameFull: Locatelli F
      – PersonEntity:
          Name:
            NameFull: Agrati C
      – PersonEntity:
          Name:
            NameFull: Silvestris N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 10
              Text: 2022 Oct 20
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 12
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1